1. Home
  2. NECB vs ALLO Comparison

NECB vs ALLO Comparison

Compare NECB & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NECB
  • ALLO
  • Stock Information
  • Founded
  • NECB 1934
  • ALLO 2017
  • Country
  • NECB United States
  • ALLO United States
  • Employees
  • NECB N/A
  • ALLO N/A
  • Industry
  • NECB Savings Institutions
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NECB Finance
  • ALLO Health Care
  • Exchange
  • NECB Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • NECB 367.2M
  • ALLO 431.9M
  • IPO Year
  • NECB N/A
  • ALLO 2018
  • Fundamental
  • Price
  • NECB $25.19
  • ALLO $1.87
  • Analyst Decision
  • NECB
  • ALLO Buy
  • Analyst Count
  • NECB 0
  • ALLO 12
  • Target Price
  • NECB N/A
  • ALLO $10.06
  • AVG Volume (30 Days)
  • NECB 68.4K
  • ALLO 2.7M
  • Earning Date
  • NECB 01-30-2025
  • ALLO 11-07-2024
  • Dividend Yield
  • NECB 2.22%
  • ALLO N/A
  • EPS Growth
  • NECB 28.30
  • ALLO N/A
  • EPS
  • NECB 3.70
  • ALLO N/A
  • Revenue
  • NECB $106,663,000.00
  • ALLO $43,000.00
  • Revenue This Year
  • NECB N/A
  • ALLO N/A
  • Revenue Next Year
  • NECB N/A
  • ALLO N/A
  • P/E Ratio
  • NECB $6.81
  • ALLO N/A
  • Revenue Growth
  • NECB 12.44
  • ALLO 26.47
  • 52 Week Low
  • NECB $14.26
  • ALLO $1.78
  • 52 Week High
  • NECB $31.72
  • ALLO $5.78
  • Technical
  • Relative Strength Index (RSI)
  • NECB 32.87
  • ALLO 36.24
  • Support Level
  • NECB $23.81
  • ALLO $1.83
  • Resistance Level
  • NECB $27.53
  • ALLO $2.12
  • Average True Range (ATR)
  • NECB 1.18
  • ALLO 0.16
  • MACD
  • NECB -0.51
  • ALLO -0.02
  • Stochastic Oscillator
  • NECB 23.27
  • ALLO 12.16

About NECB NorthEast Community Bancorp Inc.

NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. They conduct their activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: